Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. - Wikidata - wikimedia - TriplyDB

Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system.

Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system.

http://www.wikidata.org/entity/Q33509952

about

Clostridium difficile phages: still difficult?Insights into Bacteriophage Application in Controlling Vibrio Species Genetically Engineered Phages: a Review of Advances over the Last Decade Intrigues of biofilm: A perspective in veterinary medicine.Ecology of Anti-Biofilm Agents II: Bacteriophage Exploitation and Biocontrol of Biofilm Bacteria Bacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current status Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections Phage cocktails and the future of phage therapy Vibriophages Differentially Influence Biofilm Formation by Vibrio anguillarum Strains.Prevention and treatment of biofilms by hybrid- and nanotechnologies.Phage therapy against Enterococcus faecalis in dental root canals Strain Specific Phage Treatment for Staphylococcus aureus Infection Is Influenced by Host Immunity and Site of Infection Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.Classification of 17 newly isolated virulent bacteriophages of Pseudomonas aeruginosa.The use of drip flow and rotating disk reactors for Staphylococcus aureus biofilm analysis.Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention In vivo fluorescence imaging of biomaterial-associated inflammation and infection in a minimally invasive manner.A method for generation phage cocktail with great therapeutic potential.Combined treatment of Pseudomonas aeruginosa biofilms with bacteriophages and chlorine.Metabolic proximity in the order of colonization of a microbial community.Bacteriophage-mediated control of a two-species biofilm formed by microorganisms causing catheter-associated urinary tract infections in an in vitro urinary catheter model Culturable bacterial diversity from a feed water of a reverse osmosis system, evaluation of biofilm formation and biocontrol using phages.Scaffold-based anti-infection strategies in bone repair.Polymicrobial interactions: impact on pathogenesis and human disease.Novel approaches to the diagnosis, prevention, and treatment of medical device-associated infections Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells Enhancing the utility of existing antibiotics by targeting bacterial behaviour?Pseudomonas biofilms, cystic fibrosis, and phage: a silver lining?Enumerating Virus-Like Particles and Bacterial Populations in the Sinuses of Chronic Rhinosinusitis Patients Using Flow Cytometry Monitoring in Real Time the Formation and Removal of Biofilms from Clinical Related Pathogens Using an Impedance-Based Technology.Bacteriophages are synergistic with bacterial interference for the prevention of Pseudomonas aeruginosa biofilm formation on urinary catheters.A novel bacteriophage cocktail reduces and disperses Pseudomonas aeruginosa biofilms under static and flow conditions A Yersinia pestis-specific, lytic phage preparation significantly reduces viable Y. pestis on various hard surfaces experimentally contaminated with the bacterium.Antipseudomonal Bacteriophage Reduces Infective Burden and Inflammatory Response in Murine Lung.Bacteriophage Combinations Significantly Reduce Clostridium difficile Growth In Vitro and Proliferation In Vivo.Development of expanded host range phage active on biofilms of multi-drug resistant Pseudomonas aeruginosa.Reducing the risk of infection associated with vascular access devices through nanotechnology: a perspective.A Novel Antimicrobial Endolysin, LysPA26, against Pseudomonas aeruginosa Biofilm elimination on intravascular catheters: important considerations for the infectious disease practitioner.Mini-review: Antimicrobial central venous catheters--recent advances and strategies.

P2860

Q21131097-70EF7DF4-76CB-4B66-9C02-79CC73E59BDA Q26739744-74A04578-AF7B-4DE8-8A47-37EAA55118E6 Q26744156-A3EE6B3B-8C6C-49B4-9477-61009FAB03EF Q26751336-1E7EB3D9-C83E-47B0-833B-AA889C046820 Q26786947-E88EEFF1-0150-4CD0-9E8A-77426623217B Q26799417-6A377577-9632-49D9-8C1B-8D39447F86D5 Q26823401-B727C6C1-A1E6-4BFC-A132-702737B6B26A Q26995797-86C1DE59-D7B7-4432-922F-813091461BE8 Q27324015-75DB299C-6995-40B4-8E94-B4AFFB93CE25 Q27692708-2F9EE16F-B720-4B2E-B4D5-BD7F745E764A Q28071930-5599BE36-7ADE-457B-B42B-8DD80753B5CA Q28546694-589F8B37-AC5C-4C39-99A2-FAA22622A821 Q30403958-945F8DF8-F27C-40E2-BC53-B12475134EE4 Q33746414-1FF1265A-E2B4-4850-919F-7CBCB8CC3B3E Q33785675-5C676D2A-06A9-4C53-AB51-B7821196D08A Q33828309-C31A3CE5-C319-4A2D-B492-FB8780479B59 Q34161108-DD979570-7D9D-4A9F-98B1-AEBF1D7309B3 Q34187102-89197AD3-1343-4C6F-8CBE-088751079F26 Q34377473-77070147-AF02-41C0-A12E-164A995CE948 Q35035442-BE00A4D4-B041-407F-BD33-EDB68F497BD8 Q35105990-757CBFA7-C446-478B-B111-83EC4A5BD5AB Q35198665-FE0A9472-D62B-473A-9C3E-E852F4F70DA8 Q35235414-94CC9212-8D7C-4FF4-AA68-A1623874713A Q35666253-35322F59-E758-4113-A648-6D8ED49A3A42 Q35714452-1E0B1915-D93D-4873-AA52-C3A1EA8570BC Q35827006-47AAC9FD-BFB2-4946-9BCD-671ED2F4F4F7 Q35853204-CB780A1B-56D3-42AC-B268-923073E10521 Q35878716-650A1FD9-CDB9-43C8-8CDF-6690C6C3DA3C Q36015413-315A39B9-39B6-4C3F-B1A7-4AE30F54FB83 Q36151044-F9CE7AA4-3F60-4941-A157-F5A292423962 Q36409613-B05AFFE5-1B60-464A-B87D-AD46F79C0C8F Q36483482-4EB35783-31B6-4513-82D7-5E3F5194B002 Q36489653-416B5941-5BE3-4EA9-8D47-F66953F30ADD Q36571855-96845C0D-E5DA-4D51-B96C-F681B15505BB Q36571896-6EF49EDD-E3F2-4D0E-8191-3770CE57174F Q36812409-A1581390-5E97-4845-87E2-F959C62574AC Q37341004-EA9A2B52-B9AC-4C1B-B016-DF4F9DFEED58 Q37667229-F1BD51D5-95AC-471A-9B63-2073DA86ED3F Q37860818-92583947-A8EC-41D6-A2A2-C3EB44DFD980 Q37896090-F2B229A0-6FBA-4DD1-BAF6-8ED605BCC1A1

P2860

Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system.

http://www.wikidata.org/entity/Q33509952

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Bacteriophage cocktail for the ...... s in an in vitro model system.

@ast

Bacteriophage cocktail for the ...... s in an in vitro model system.

@en

type

label

Bacteriophage cocktail for the ...... s in an in vitro model system.

@ast

Bacteriophage cocktail for the ...... s in an in vitro model system.

@en

prefLabel

Bacteriophage cocktail for the ...... s in an in vitro model system.

@ast

Bacteriophage cocktail for the ...... s in an in vitro model system.

@en

P1433

Q33509952-6D62184D-77F1-42D2-ADF9-63958522EC6E

P1476

Q33509952-F9E152DC-A7BE-423F-8F5E-1F7A6D027B93

P2093

Q33509952-05387635-6C9D-4F0E-9472-60EC84ABFB8A

Q33509952-0FAB59C2-B338-4E57-B9BA-AB8119B9A0B4

Q33509952-70BE619B-3A1D-4EB6-90C9-A0B53BF98A7E

Q33509952-8711E858-AFC8-4325-985F-664C8A171386

Q33509952-962AA821-AD69-4501-B226-AB574598A104

P2860

Q33509952-03B675F3-BDCC-4C8E-8814-13A04AEA5776

Q33509952-096D3A87-8223-4EF5-B067-BB957418D3B9

Q33509952-12A7087B-DFA6-4388-8D50-C4C7B94F829A

Q33509952-15D084CC-7124-47A1-8C95-D0529BCBED70

Q33509952-168EDDB5-D07B-4D8D-8CE4-FD5E3D087FC8

Q33509952-1DD99370-EC24-494E-879C-B279E361B0FC

Q33509952-2E37E605-B0C4-4ECE-A623-87641EB678A3

Q33509952-355AF210-43D8-40AB-9C2E-B7C42AC71DA3

Q33509952-3B1F6479-6C64-46B0-AB2D-B58199B0B32A

Q33509952-411AFE20-5A1D-4D65-BC09-66CED1D48BDF

P304

Q33509952-38C8416F-8606-4AAC-998B-E21CEDFDC108

P31

Q33509952-BFEC4C1A-F552-43DF-9785-DAE6BC67061A

P356

Q33509952-F7AADCD8-7732-4A5E-8387-3209908EDA8B

P407

Q33509952-B6FD6575-EF11-4C70-B0C5-48E0A6E2D09D

P433

Q33509952-AF6D4A49-AC9B-4FCC-A233-298B39D5C53C

P478

Q33509952-219E4632-AB04-4343-8C47-211B064EBD79

P50

Q33509952-2CCD0E4C-6291-4220-8F20-6CC0E3D2ADA4

P577

Q33509952-4846518C-8960-4B56-B66D-70F3C59D8237

P5875

Q33509952-D2DB1B0D-9C71-438A-95A7-12771EAC6DA2

P698

Q33509952-FD737B74-E390-417B-A005-7203F7FA7765

P921

Q33509952-2AC954F3-801E-497B-AC94-234A3FE8FA41

Q33509952-560B6DA5-C507-4CCC-A86B-5755DD7B6AA1

Q33509952-69C42E49-E731-475E-9EB9-898EF07C9FCE

Q33509952-FBF3BD08-2BE9-41DC-AA7A-F731A02E4AE6

P932

Q33509952-46920099-F158-4D03-8871-79E4C64BD2AE

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Bacteriophage cocktail for the ...... rs in an in vitro model system

@en

P2093

John J Curtin

http://www.w3.org/2001/XMLSchema#string

Oren Mayer

http://www.w3.org/2001/XMLSchema#string

Rodney M Donlan

http://www.w3.org/2001/XMLSchema#string

Susan M Lehman

http://www.w3.org/2001/XMLSchema#string

Terri Forster

http://www.w3.org/2001/XMLSchema#string

P2860

CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes

Biofilms: survival mechanisms of clinically relevant microorganisms.

Antibiotics and prevention of microbial colonization of catheters

Dispersing biofilms with engineered enzymatic bacteriophage

Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis

Bacteriophage T4 multiplication in a glucose-limited Escherichia coli biofilm.

Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals

Bacteriophage therapy of bacterial infections: an update of our institute's experience.

Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention.

Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis.

P304

397-404

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00669-09

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26888363

http://www.w3.org/2001/XMLSchema#string

P698

19822702

http://www.w3.org/2001/XMLSchema#string

P921

catheterization

Pseudomonas aeruginosa

P932

2798481

http://www.w3.org/2001/XMLSchema#string